This trial will test a new non-invasive treatment for restless legs syndrome (RLS). The study will compare the new treatment to a sham (fake) treatment, and will test how well the treatment works and how well tolerated it is.
3 Primary · 9 Secondary · Reporting Duration: 90 minutes
40 Total Participants · 2 Treatment Groups
Primary Treatment: Active neurostimulation · Has Placebo Group · N/A
Age 22 - 89 · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: